|
The device was not returned for analysis.The analysis is therefore only based on the inspection of the returned device data.The returned device data have been inspected.During the inspection, the battery status eri could be confirmed because of an unexpectedly low battery voltage.This inconsistency of battery voltage and current consumption was detected leading to the activation of the eri status.In order to exclude any potential harm for the patient we therefore would like to recommend to replace the device and to return it for analysis to biotronik.Of course, individual circumstances and medical judgment determine decisions about patient care.The above recommendation is based on a purely technical assessment.Should additional relevant information or the device itself become available, the investigation will be updated.
|
|
This device was explanted and replaced.Upon receipt, the interrogation of the implantable cardioverter defibrillator revealed the device status eos which was detected by the device after the explant on (b)(6) 2019.The device history record was inspected, documenting that the device performed as expected during the device manufacturing.The icd was subjected to an electrical analysis.Therefore the eos status was removed and the ability of the device to deliver therapies was verified.The anti-bradycardia pacing pulses proved to be normal and in amplitude and frequency as programmed.A fibrillation signal was applied and the device delivered a defibrillation shock.However, the specified energy level was not reached.The icd was opened and the inner assembly was inspected.The visual inspection of the inner assembly showed no anomalies.The measurement of the battery voltage showed a depleted battery.The electronic module was attached to an external power supply to test the functionality of the module.Thereby, the electrical parameters, particularly the current consumption of the electronic module were found to be normal and as expected.The ability of the electronic module to deliver therapies was verified.The anti-bradycardia pacing pulses proved to be normal and in amplitude and frequency as programmed.A fibrillation signal was applied and the device delivered a defibrillation shock as specified, documenting a normal and expected sensing and shock delivery.In particular, the specified energy level was reached.The battery was sent to the manufacturer for further analysis.The manufacturing records of the battery were inspected, documenting that the battery parameters were within specification during the battery manufacturing.No anomalies were documented during the production process, associated with this battery.The visual inspection of the battery did not reveal any external signs of damage.The voltage measurement confirmed the battery depletion and the microcalorimetry analysis showed elevated heat dissipation.At a next step, the battery was opened for destructive analysis and the inner assembly was inspected.The analysis identified a damaged insulation, which led to an increased internal self depletion and, as a result, to the clinical observation.In conclusion, premature battery depletion was confirmed by analysis.Bench testing on the device was performed, and no sources of high current were noted.The electronic module worked as expected with an external power supply.The premature battery depletion was caused by insulation damage within the battery.
|